Bakri Balloon for Treatment of Postpartum Hemorrhage: A Real-World 2016-2020 Study in 279 Women from a Single Center

01 March 2023 : Clinical Research

Chanyun Xiao^1BCEF, Ying Wang^1BCEF, Na Zhang^1ADEG*, Guo-qiang Sun^1ADF

DOI: 10.12659/MSM.938823

Med Sci Monit 2023; 29:e938823

Background Material and Methods Results Discussion Conclusions References

Related articles Order reprints Share article Share by email

View HTML version

Table 1 Comparison of patients’ characteristics between Failure group and Success group.

	Failure group (n=31)	Success group (n=248)	t/χ2	P
Weight (mean±SD, kg)	70.15±1.57	71.97±0.66	−0.937	0.350
Gestational age (mean±SD, w)	39.08±0.51	39.03±0.12	0.147	0.883
Maternal age (n, %)
18–25 year	3 (9.68)	29 (11.69)	3.085	0.080
25–35 year	25 (80.64)	174 (70.16)
≥35 year	3 (9.68)	45 (18.15)
Parity (n, %)
Primipara	24 (77.42)	168 (67.74)	1.203	0.273
Multipara	7 (22.58)	80 (32.26)	1.203	0.273
Delivery mode (n, %)
Vaginal delivery	21 (67.74)	149 (60.08)	0.679	0.410
Cesarean section	10 (32.26)	99 (39.92)	0.679	0.410
Birth number (n, %)
Single births	29 (93.55)	235 (94.76)	0.079	0.778
Multiple births	2 (6.45)	13 (5.24)	0.079	0.778
Repeat cesarean section (n, %)
No	31 (1)	234 (94.35)	1.842	0.175
Yes	0 (0.00)	14 (5.65)	1.842	0.175
Gestational diabetes (n, %)
No	31 (1)	243 (97.98)	0.636	0.425
Yes	0 (0.00)	5 (2.02)	0.636	0.425
Gestational hypertension (n, %)
No	29 (93.55)	241 (97.18)	1.163	0.281
Yes	2 (6.45)	7 (2.82)	1.163	0.281
Uterine atony (n, %)
No	7 (22.58)	63 (25.40)	0.117	0.733
Yes	24 (77.42)	185 (74.60)	0.117	0.733
Placenta accreta (n, %)
No	12 (38.71)	119 (47.98)	0.952	0.329
Yes	19 (61.29)	129 (52.02)	0.952	0.329
Abnormal coagulation (n, %)
No	30 (96.77)	244 (98.39)	0.407	0.523
Yes	1 (3.23)	4 (1.61)	0.407	0.523
Placenta previa (n, %)
No	31 (1)	238 (95.97)	1.296	0.255
Yes	0 (0.00)	10 (4.03)	1.296	0.255
Preeclampsia (n, %)
No	29 (93.55)	242 (97.58)	1.609	0.205
Yes	2 (6.45)	6 (2.42)	1.609	0.205
SD – standard deviation.

Back to the Article